Patient Experience Data: Putting patients at the centre of rare drug development
Speaking session hosted by Samantha Morrison
Menu
Despite our world-class team and industry-leading insight platforms we recognise that healthcare is a constantly evolving, multi-faceted arena that requires strong partnerships to ensure excellence and compliance
We have found that some of the best ways to connect with our fellow pharmaceutical professionals are through attending, displaying and presenting at conferences across the globe. They give us valuable opportunities to show our methods, ideas and company values as well demonstrating how we influence the rare disease landscape, make new connections and enhancing exisiting ones
When P4A attend conferences we deliver accurate insights, predictions and analysis of the big issues facing medicine.
2024
Speaking session hosted by Samantha Morrison
2023
Speaking session hosted by Sophie Schmitz
Speaking session hosted by Akshay Kumar
Roundtable hosted by Akshay Kumar & Marco Crisci
2023
Speaking session hosted by Akshay Kumar
2023
Speaking session hosted by Sophie Schmitz
Roundtable Presentation : Josephina Haberl & Fisentzos Stylianou
2022
Speaking session hosted by Sophie Schmitz
2022
Speaking session hosted by Joanna Fernandes and Sophie Schmitz
Speaking session hosted by Sophie Schmitz & Neil Bertelsen
2022
2022
Speaking session hosted by Sophie Schmitz
2021
Speaking session hosted by Joanna Fernandes and Sophie Schmitz
2021
2021
2020
2020
2019
Speaking session hosted by Sophie Schmitz & Darren Walsh
2019
2019
Speaking session hosted by Sophie Schmitz
2018
Speaking session hosted by Sophie Schmitz & Christina Poschen
2017
Speaking session hosted by Sophie Schmitz
Akshay is a Partner at Partners4Access. Akshay has 13+ years of experience helping pharmaceutical and biotech companies develop market access & pricing solutions – which are aligned to their broader commercial, organizational and environmental context.
These solutions could be at the product, process and/or capability level. Besides market access, Akshay also has supported pharmaceutical companies in allied commercial areas such as – epidemiology, opportunity assessments, product positioning, product performance tracking, customer insights, and organizational design.
Prior to joining Partners4Access, Akshay worked at Huron Consulting as Senior Director – Orphan Drugs, Cell & Gene Therapy commercialization and at ZS Associates initially as European Market Access and Pricing Lead and then as Global Epidemiology Practice Lead. He holds a D.Phil (PhD) in Materials from University of Oxford.
Sophie is Managing Partner at Partners4Access, the global access experts for orphan drugs, cell and gene therapy. She brings a wealth of commercial and access experience across orphan and cell and gene therapies to the benefit of clients. She plays an active role in advising clients on price and market access strategies, with the ultimate goal of optimizing fair access for all stakeholders in rare disease.
Her 20+ year career spans various disease areas and medical devices, successfully supporting the strategy development and operationalization for orphan drugs. Her extensive industry experience across several product launches ensures clients benefit from that knowledge and build stronger access strategies as a result. Managing global, regional and local teams has provided her with the know-how to successfully face the real-life challenges in today’s orphan, cell and gene therapy world.
Joanna’s main responsibilities at P4A include developing current and future landscape assessments, market research, and funding analysis, including innovative payment methods. Her key focus is on Cell and Gene therapy but has worked on a number of projects across a range of therapy areas, including immune-oncology, rare and ultra-rare diseases.
She has completed a B.Sc. in Biochemistry at Imperial College London, focusing on infectious diseases and biotechnology. Prior to Partners4Access, she worked as an analyst at Finalta, Mckinsey Solutions, allowing her to further develop her primary and secondary research skills.
